Showing results (211-220 of 255) with videos related to
Sort By:
Pageof 26
Journal of Chromatography|June 29, 1990
Determination of the active metabolite of molsidomine in human plasma by reversed-phase high-performance liquid chromatographyC Dutot, J Moreau, P Cordonnier, et al.Acta Psychiatrica Scandinavica|November 18, 2003
Accuracy of self-report and toxicological assays to detect substance misuse disorders in parasuicide patientsM Tournier, M Molimard, A Abouelfath, et al.Respiratory Medicine|July 6, 2010
Omalizumab reduces oral corticosteroid use in patients with severe allergic asthma: real-life dataM Molimard, R Buhl, R Niven, et al.Allergy|February 15, 2007
Omalizumab decreases nonspecific airway hyperresponsiveness in vitroP Berger, E Scotto-Gomez, M Molimard, et al.Pediatric Research|September 25, 2001
Prolonged moderate hyperoxia induces hyperresponsiveness and airway inflammation in newborn ratsD Denis, M J Fayon, P Berger, et al.Therapie|July 1, 1989
[Influence of surgical biliary pathology on the diffusion of ceftriaxone in the biliary tract]L Guyot, E Naline, J Moreau, et al.Biochemical and Biophysical Research Communications|May 15, 1992
Neurokinin A (NK2) receptor revisited with SR 48968, a potent non-peptide antagonistC Advenier, N Rouissi, Q T Nguyen, et al.The American Review of Respiratory Disease|November 1, 1992
Effects on the isolated human bronchus of SR 48968, a potent and selective nonpeptide antagonist of the neurokinin A (NK2) receptorsC Advenier, E Naline, L Toty, et al.Therapie|January 1, 1991
[Diffusion of minocycline in pulmonary tissue]E Naline, J P Roudière, P Cordonnier, et al.British Journal of Pharmacology|August 1, 1997
The spasmogenic effects of vanadate in human isolated bronchusJ Cortijo, V Villagrasa, M Martí-Cabrera, et al.Pageof 26